Regeneus Financial Data

Company name:Regeneus LtdStatus:Active
End of fiscal year:June 29 2018ISINAU000000RGS6
Auditor:Grant Thornton Audit Pty LtdYear established:2007
Company sector name:HealthcareTrading currency:AUD
Industry name:BiotechnologyPlace of incorporation:Australia (AU)
Industry group nameBiotechnologyDoing business in:Australia (AU)
Address25 Bridge Street
Pymble, 2073
Tel.:+61 294998010
City/Country:Sydney, AustraliaFax:+61 294998020
Web address:http://www.regeneus.com.au
Company description:Regeneus Ltd clinical-stage regenerative medicine company. It mainly develops a portfolio of cell-based therapies to address significant cant unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases. The company uses stem cell and immuno-oncology technologies to develop cell-based therapies. The pipeline products of the company are Progenza which is an allogeneic stem cell therapy technology platform; RGSH4K which is a human cancer vaccine; CryoShot Canine which is an allogeneic stem cell for canine and equine osteoarthritis; CryoShot Equine and Kvax.
Price Price change [%] Bid Offer Open High Low Volume
0.1425  -0.0025[-1.72%] 0.135 0.145 0.145 0.145 0.14 64,729
Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
30.288345735 208.885143 -0.30 -0.03 - -5.80 - 0.05 - 0.20

RGS KEY FIGURES (at previous day's close)

Yesterday's Close
0.15
PE Ratio
-5.80
Market Capitalisation
30.29M
Latest Shares Outstanding
208.89M
Earnings pS (EPS)
-0.03
Dividend pS (DPS)
-
Dividend Yield
-
Sales per Employee
-
Effective Tax Rate
-
Foreign Sales
-
Domestic Sales
-
Selling, General & Adm/tive (SG...
684.27%
Research & Devlopment (R&D) as ...
0.00%
Gross Profit Margin
100.00%
EBITDA Margin
-
Pre-Tax Profit Margin
-
Assets Turnover
8.66%
Return on Assets (ROA)
-0.73%
Return on Equity (ROE)
-0.94%
Return on Capital Invested (ROC...
-0.80%
Current Ratio
2.37
Leverage Ratio (Assets/Equity)
1.71%
Interest Cover
-199.47
Total Debt/Equity (Gearing Rati...
0.34%
LT Debt/Total Capital
-
Working Capital pS
0.02
Cash pS
0.01
Book-Value pS
0.02
Tangible Book-Value pS
0.00
Cash Flow pS
-
Free Cash Flow pS
-0.02
Spread
0.01
Gross gearing
0.00%
Net Debt
-1.09M

RGS Balance Sheet Chart (June 29 2018)

:liab eq:assets
Period † High Low
1 Week0.16250.14
1 Month0.170.14
3 Months0.200.11
6 Months0.200.059
1 Year0.200.049
3 Years0.270.049
5 Years0.270.049

Share price performance previous 3 years

Share price performance intraday

Period † Open Open Avg. VWAP Min Vol Max Vol Avg. Daily Vol Change %
1 Week0.16250.1450.14425846,724447,540205,072-0.02-12.31%
1 Month0.160.1521050.15141926,904500,401179,323-0.0175-10.94%
3 Months0.110.1546360.1567255,81811,049,737622,7350.032529.55%
6 Months0.0610.1139910.1416144,74611,049,737384,0920.0815133.61%
1 Year0.0770.094990.1247691,63411,049,737274,2950.065585.06%
3 Years0.130.1206040.1337454811,049,737201,6600.01259.62%
5 Years0.120.1277920.1378751911,049,737187,1910.022518.75%

RGS Growth Ratios (June 29 2018)

1 year 3 years 5 years 10 years
Diluted EPS growth
-
-
-
-
Diluted continuous EPS growth
-
-
-
-
Dividend growth
-
-
-
-
Equity per share growth
-0.64
-0.29
-0.28
-
Revenue growth
-0.94
-0.32
-
-
Operating income growth
-
-
-
-
Net income growth
-
-
-
-
Net income cont growth
-
-
-
-
CFO growth
-
-
-
-
FCF growth
-
-
-
-
Operating revenue growth
-0.94
-0.32
-
-

RGS Income Statement June 29 2018 (AUD)

Total Revenue
0.575406
Operating Revenue
0.575406
Gross Profit
0.575406
Operating Expenses
7.893994
Selling,General and Administr...
3.937355
General and Administrative Ex...
3.937355
Rent and Landing Fees
0.474939
OtherGandA
3.462416
Research and Development
3.956639
Operating Income
-7.318588
Interest Income/Expense,Net-N...
9,243.00
Interest Income-Non Operating
0.035105
Interest Expense-Non Operatin...
0.025862
Other Income/Expense,Net
2.124745
Earnings from Equity Interest
-0.03985
Other Non-Operating Income/Ex...
2.164595
Pretax Income
-5.1846
Provision for Income Tax
0.00
Net Income Available to Commo...
-5.1846
Net Income
-5.1846
Net Income Including Noncontr...
-5.1846
Net Income from Continuing Op...
-5.1846
Basic EPS
-0.03
Basic EPS from Continuing Ope...
-0.03
Basic EPS from Discontinued O...
0.00
Diluted EPS
-0.03
Diluted EPS from Continuing O...
-0.03
Diluted EPS from Discontinued...
0.00
Basic Weighted Average Shares...
208.885143
Diluted Weighted Average Shar...
208.885143
Net Income from Continuing an...
-5.1846
Normalized Income
-5.1846
Basic EPS,Continuing and Disc...
-0.03
Diluted EPS,Continuing and Di...
-0.03
Interest and Dividend Income
0.035105
Interest Expense
0.025862
Net Interest Income
9,243.00
Earning Before Interest and T...
-5.158738
Earning Before Interest Tax D...
-5.158738
Net Income from Continuing Op...
-5.1846
Normalized Basic EPS
-0.03
Normalized Diluted EPS
-0.03
NormalizedEBITDA
-5.158738
Tax rate for calculations
0.00

RGS Efficency Ratios (June 29 2018)

Days in sales
0.24
Days in inventory
-
Days in payment
-
Cash conversion cycle
-
Receivable turnover
1,494.56
Inventory turnover
-
Payable turnover
-
Fixed assets turnover
1.12
Assets turnover
0.08
ROE
-0.94
ROA
-0.73
ROIC
-0.80
FCF sales ratio
-
FCF net income ratio
-
Capital expenditure sales ratio
0.26

RGS Financial Health Ratios (June 29 2018)

Current ratio
2.37
Quick ratio
1.09
Debt total capital ratio
-
Debt equity ratio
-
Financial leverage
1.71
Total debt to equity
0.34

RGS Avearge Growth Ratios Over 5 Years (June 29 2018)

Growth ann capital spending
-
Growth ann gross profit
-
Avg gross margin
0.74
Avg post tax margin
-4.38
Avg pre tax marginr
-4.38
Avg net profit
-4.38
Avg ret commonr
-0.54
Avg ret assets
-0.43
Avg ret invested capital
-0.49

RGS Profitability Ratios (June 29 2018)

Gross margin
1.00
Operating margin
-12.72
EBT margin
-9.01
Tax rate
-
Net margin
-9.01
Sales per employee
-
EBIT margin
-8.97
EBITDA margin
-8.97
Normalized net profit margin
-9.01
Interest coverage
-199.47
Inc per employee tot ops
-

RGS Valuation Ratios (June 28 2018)

Sales per share
0.01
Growth ann sales per share 5 ye...
-
Book value per share
0.03
CF per share
0.01
Price to EPS
-
Ratio PE 5 year high
-
Ratio PE 5 year low
-
Price to book
4.65
Price to sales
11.61
Price to cash flow
8.55
Price to free cash flow
9.28
Div rate
-
Dividend yield
-
Div payout tot ops
-
Div payout 5 year
-
Payout ratio
0.00
Sustainable growth rate
-0.50
Cash return
0.12

RGS Balance Sheet June 29 2018 (AUD)

Total Assets
4.983129
Current Assets
4.312974
Cash,Cash Equivalents,and Sho...
1.091579
Cash and Cash Equivalents
1.091579
Cash
1.091579
Receivables
0.896157
Loans Receivable
0.896157
Inventories
0.015336
Raw Materials
0.031733
Inventories Adjustments/Allow...
-0.016397
Prepaid Assets and Others
0.044044
Other Current Assets
2.265858
Total Non-Current Assets
0.670155
Net Property,Plant,and Equipm...
0.417248
Gross Property,Plant,and Equi...
1.978953
Machinery,Furniture/Equipment
0.758172
Other Properties
1.220781
Accumulated Depreciation
-1.561705
Goodwill and Other Intangible...
1,644.00
Other Intangible Assets
1,644.00
Investments and Advances
0.041263
Long term equity investment
0.041263
Investments in Associates, at...
0.041263
Other Non-Current Assets
0.21
Total Liabilities
2.061364
Current Liabilities
1.818607
Payables and Accrued Expenses
0.707209
Payables
0.707209
Accounts Payable
0.372157
Other Payable
0.335052
Pension and Other Post-Retire...
0.111398
Current Debt and Capital Leas...
1
Current Debt
1
Other Current Borrowings
1
Total Non-Current Liabilities
0.242757
Provisions,Long Term
0.0537
Employee Benefits
0.189057
Pension and Other Postretirem...
0.189057
Total Equity
2.921765
Stockholder's Equity
2.921765
Capital Stock
31.076819
Common Stock
31.076819
Retained Earnings
-29.774504
Accumulated Gains/ Losses Not...
1.61945
Other Equity Adjustments
1.61945
Total Capitalization
2.921765
Common Stock Equity
2.921765
Net Tangible Assets
2.920121
Working Capital
2.494367
Invested Capital
3.921765
Tangible Book Value
2.920121
Total Debt
1
Ordinary Shares Number
208.885143
TotalLiabilitiesAsReported
2.061364
TotalEquityAsReported
2.921765

RGS Cash Flow June 29 2018 (AUD)

Classes of Cash Receipts from...
3.224439
Receipts from Customers
0.616216
Other Cash Receipts from Oper...
2.608223
Classes of Cash Payments
-7.458867
Payments to Suppliers for Goo...
-7.458867
Interest Paid, Direct
-0.025862
Interest Received, Direct
0.01325
Cash Flow from Investing Acti...
-0.150966
Cash Flow from Continuing Inv...
-0.150966
Purchase/Sale of Property,Pla...
-0.150966
Purchase of Property,Plant an...
-0.150966
Cash Flow from Financing Acti...
1.354449
Cash Flow from Continuing Fin...
1.354449
Issuance/Payments of Debt,Net
1.354449
Issuance/Payments of Long Ter...
1.354449
Proceeds or Issuance of Long ...
1.354449
Cash and Cash Equivalents,End...
1.091579
Change in Cash
-3.043557
Cash and Cash Equivalents,Beg...
4.135136
Interest Paid, Supplemental D...
0.025862
Capital Expenditure
-0.150966
Issuance of Debt
1.354449
Free Cash Flow
-4.398006
ChangeinCashSupplementalAsRep...
-3.043557
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201025 04:25:26